 |
|
|
 |
 |
 |
 |
 |
Contact Us
|
 |
 |

|
 |
 |
 |
 |
Dr. Salvatore L. DeLellis
1264 South Pinellas Ave. (Alt. 19)
Tarpon Springs,
FL
34689
info@footankledoctor.com
(727) 937-6398
|
|
|
 |
|
 |
 |
 |

|
 |
|
|
|
|

|


|

-
-


MicroVascular Therapy (MVT), a New Revolutionary System for the Prevention and Treatment of: Neuropathy, Wound Care and Ulcers.
Exclusively marketed worldwide by neuroVasix, inc., MicroVas® is a patented, non-invasive vascular treatment device that delivers a deeply penetrating waveform that drains the venous beds and raises oxygen levels in damaged tissue to accelerate healing. An important new tool in the treatment of neuropathy, non-healing wounds, repetitive motion disorders, fibromyalgia, sports injuries and many other conditions related to vascular insufficiency, MicroVas’ therapeutic effects are dramatic and long lasting.
A review of several of the alternate technologies on the market today may be in order to contrast with MicroVas. Hyperbaric oxygen therapy has been shown to be effective in healing ischemic ulcers. 100% oxygen at 2 atmospheres will give a partial pressure of oxygen 10 times normal. This greatly increases the rate of diffusion through the open face of the ulcer. Skin however, is not as permeable to oxygen diffusion and oxygen delivery depends upon intact circulation as well. Hyperbaric oxygen therapy is a passive process and does not alter the underlying disease in the microcirculation. This is in contrast to MicroVas, which appears to significantly remodel the microcirculation as part of its therapeutic effect. MicroVas results in a more permanent improvement.
Involuntary Exercise:
Pain Management:
-
Eases pain transmission
-
Stimulates endorphins
Increased Blood Flow and Tissue Oxygenation:
-
MicroVas immediately and dramatically increases blood flow
-
Elevates tissue oxygenation
-
Aids in rebuilding tissue
-
Boosts exchange of nutrients
Lymphatic Drainage:
-
Boosts lymphatic drainage
-
Relieves swelling and inflammation -
Boosts the body’s immune responses
|
| |  | |
|

|
|
|